Preneoplastic somatic mutations including


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
21 01 2022
Historique:
entrez: 19 1 2022
pubmed: 20 1 2022
medline: 20 4 2022
Statut: ppublish

Résumé

Normal cell counterparts of solid and myeloid tumors accumulate mutations years before disease onset; whether this occurs in B lymphocytes before lymphoma remains uncertain. We sequenced multiple stages of the B lineage in elderly individuals and patients with lymphoplasmacytic lymphoma, a singular disease for studying lymphomagenesis because of the high prevalence of mutated

Identifiants

pubmed: 35044826
doi: 10.1126/sciadv.abl4644
pmc: PMC8769557
doi:

Substances chimiques

Myd88 protein, mouse 0
Myeloid Differentiation Factor 88 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabl4644

Références

Science. 2018 Nov 23;362(6417):911-917
pubmed: 30337457
Cancer Cell. 2011 Aug 16;20(2):246-59
pubmed: 21840488
Leukemia. 2012 Sep;26(9):1986-2010
pubmed: 22948490
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):255-60
pubmed: 24367082
Sci Rep. 2017 Oct 13;7(1):13124
pubmed: 29030609
Haematologica. 2018 May;103(5):865-873
pubmed: 29449433
Blood Adv. 2019 Nov 12;3(21):3360-3374
pubmed: 31698464
Leukemia. 2013 Aug;27(8):1722-8
pubmed: 23446312
J Clin Oncol. 2020 Apr 10;38(11):1198-1208
pubmed: 32083995
Sci Transl Med. 2014 May 28;6(238):238ra71
pubmed: 24871132
Science. 2020 Mar 27;367(6485):1449-1454
pubmed: 32217721
Blood. 2014 Mar 13;123(11):1637-46
pubmed: 24366360
Nat Genet. 2020 Jun;52(6):604-614
pubmed: 32424351
Blood. 2013 Mar 14;121(11):2051-8
pubmed: 23321251
Blood Cancer J. 2017 May 26;7(5):e565
pubmed: 28548645
Haematologica. 2012 Sep;97(9):1281-90
pubmed: 22773606
N Engl J Med. 2018 Mar 29;378(13):1189-1199
pubmed: 29601269
Genome Res. 2019 Apr;29(4):635-645
pubmed: 30894395
Nature. 2019 Oct;574(7779):532-537
pubmed: 31645730
Bioinformatics. 2017 Oct 01;33(19):3088-3090
pubmed: 28575171
PLoS Comput Biol. 2010 Dec 02;6(12):e1001025
pubmed: 21152010
Nature. 2018 Aug;560(7718):387-391
pubmed: 29925955
Front Immunol. 2021 May 04;12:641692
pubmed: 34017329
Am J Hematol. 2021 Jul 1;96(7):E250-E253
pubmed: 33819355
Genome Res. 2009 Sep;19(9):1553-61
pubmed: 19602639
Science. 2020 Oct 2;370(6512):75-82
pubmed: 33004514
Blood. 2020 Oct 1;136(14):1599-1605
pubmed: 32736382
Leuk Lymphoma. 2020 Oct;61(10):2527-2529
pubmed: 32508223
Nat Commun. 2016 Jun 14;7:11889
pubmed: 27297662
N Engl J Med. 2017 May 11;376(19):1835-1848
pubmed: 28489996
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Leukemia. 2017 Oct;31(10):2094-2103
pubmed: 28104919
Blood. 2014 Jun 26;123(26):4120-31
pubmed: 24711662
Science. 2020 Jul 17;369(6501):325-329
pubmed: 32675375
Nat Commun. 2019 Jul 16;10(1):3120
pubmed: 31311926
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
Cancer Cell. 2011 Aug 16;20(2):135-6
pubmed: 21840478
Nat Rev Cancer. 2005 Nov;5(11):899-904
pubmed: 16327766
Nature. 2019 Oct;574(7779):538-542
pubmed: 31645727
Blood. 2021 Mar 25;137(12):1615-1627
pubmed: 33025009
N Engl J Med. 2018 Jan 18;378(3):241-249
pubmed: 29342381
Br J Haematol. 2021 Mar;192(5):843-852
pubmed: 32780894
Front Immunol. 2020 Dec 01;11:602868
pubmed: 33343574
Blood. 2017 Jan 19;129(3):347-357
pubmed: 27903527
Cell. 2020 Aug 6;182(3):672-684.e11
pubmed: 32697969
Haematologica. 2018 Sep;103(9):e408-e411
pubmed: 29599202
Br J Haematol. 2015 Jul;170(1):134-8
pubmed: 25582069
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9014-9019
pubmed: 30992375
PLoS One. 2012;7(12):e51422
pubmed: 23284693
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Cell. 2019 Apr 18;177(3):608-621.e12
pubmed: 30955891
Hum Genomics. 2014 Jun 30;8:11
pubmed: 24980617
Haematologica. 2019 Dec;104(12):2337-2348
pubmed: 31699794
Blood. 2020 Oct 1;136(14):1590-1598
pubmed: 32746453
Nature. 2011 Feb 3;470(7332):115-9
pubmed: 21179087
Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):168-71
pubmed: 21856552
Hum Mol Genet. 2015 Apr 15;24(8):2125-37
pubmed: 25552646
Br J Haematol. 2020 Jun;189(6):1165-1170
pubmed: 32103491
Nature. 2020 Feb;578(7794):266-272
pubmed: 31996850
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Cell. 2021 Apr 15;184(8):2239-2254.e39
pubmed: 33831375
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv41-iv50
pubmed: 29982402
Haematologica. 2018 Jun;103(6):1029-1037
pubmed: 29567768
Blood. 2013 Aug 15;122(7):1222-32
pubmed: 23836557
Leukemia. 2014 Jan;28(1):166-73
pubmed: 23604227
Nucleic Acids Res. 2011 Sep 1;39(17):e118
pubmed: 21727090
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
BMC Dev Biol. 2001;1:4
pubmed: 11299042
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Nature. 2019 Jan;565(7739):312-317
pubmed: 30602793
Blood. 2015 Apr 9;125(15):2370-80
pubmed: 25655603
Leukemia. 2019 May;33(5):1219-1230
pubmed: 30353030
Blood. 2020 Aug 6;136(6):684-697
pubmed: 32325488
Blood. 2016 Jun 2;127(22):2732-41
pubmed: 27048211
Nat Med. 2018 Jul;24(7):1015-1023
pubmed: 29988143
Cancer Discov. 2014 Sep;4(9):1088-101
pubmed: 24920063
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7396-401
pubmed: 16651521
Nature. 2020 Apr;580(7805):640-646
pubmed: 32350471
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13789-94
pubmed: 16940357
Cancer Cell. 2021 Feb 8;39(2):125-129
pubmed: 33220180
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Br J Haematol. 2018 Feb;180(4):578-581
pubmed: 27748515

Auteurs

Sara Rodriguez (S)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Jon Celay (J)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Ibai Goicoechea (I)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Cristina Jimenez (C)

Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC, Salamanca, Spain.

Cirino Botta (C)

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

Maria-José Garcia-Barchino (MJ)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Juan-Jose Garces (JJ)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Marta Larrayoz (M)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Susana Santos (S)

Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal.

Diego Alignani (D)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Amaia Vilas-Zornoza (A)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Cristina Perez (C)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Sonia Garate (S)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Sarai Sarvide (S)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Aitziber Lopez (A)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Hans-Christian Reinhardt (HC)

Department of Hematology and Stem Cell Transplantation, West German Cancer Center, DKTK Partner Site Essen, Center for Molecular Biotechnology, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.

Yolanda R Carrasco (YR)

Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB)-CSIC, Madrid, Spain.

Isidro Sanchez-Garcia (I)

Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Maria-Jose Larrayoz (MJ)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Maria-Jose Calasanz (MJ)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Carlos Panizo (C)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Felipe Prosper (F)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Jose-Maria Lamo-Espinosa (JM)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Marina Motta (M)

Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.

Alessandra Tucci (A)

Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.

Antonio Sacco (A)

Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy.

Massimo Gentile (M)

Department of Oncohematology, "Annunziata" Hospital, Cosenza, Italy.

Sara Duarte (S)

Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal.

Helena Vitoria (H)

Hospital de S. Teotónio, Viseu, Portugal.

Catarina Geraldes (C)

Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal.

Artur Paiva (A)

Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal.

Noemi Puig (N)

Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC, Salamanca, Spain.

Ramon Garcia-Sanz (R)

Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC, Salamanca, Spain.

Aldo M Roccaro (AM)

Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy.

Gema Fuerte (G)

Mission Bio, San Francisco, CA, USA.

Jesus F San Miguel (JF)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Jose-Angel Martinez-Climent (JA)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Bruno Paiva (B)

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH